Correlation Between Revolution Medicines and Q32 Bio

Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Q32 Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Q32 Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Revolution Medicines and Q32 Bio, you can compare the effects of market volatilities on Revolution Medicines and Q32 Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Q32 Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Q32 Bio.

Diversification Opportunities for Revolution Medicines and Q32 Bio

-0.08

Correlation Coefficient

Revolution Medicines  Q32 Bio

Good diversification

The 3 months correlation between Revolution and Q32 is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Q32 Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Q32 Bio and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Q32 Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Q32 Bio has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Q32 Bio go up and down completely randomly.

Pair Corralation between Revolution Medicines and Q32 Bio

Given the investment horizon of 90 days Revolution Medicines is expected to under-perform the Q32 Bio. But the stock apears to be less risky and, when comparing its historical volatility, Revolution Medicines is 6.23 times less risky than Q32 Bio. The stock trades about -0.04 of its potential returns per unit of risk. The Q32 Bio is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  156.00  in Q32 Bio on May 1, 2025 and sell it today you would earn a total of  56.00  from holding Q32 Bio or generate 35.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Revolution Medicines  vs.  Q32 Bio

Revolution Medicines

Risk-Adjusted Performance

Very Weak

Over the last 90 days Revolution Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Revolution Medicines is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Q32 Bio

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Q32 Bio are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Q32 Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Revolution Medicines and Q32 Bio

The main advantage of trading using opposite Revolution Medicines and Q32 Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Q32 Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q32 Bio will offset losses from the drop in Q32 Bio's long position.

The idea behind Revolution Medicines and Q32 Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.